Douglas A. Bergman

591 total citations
15 papers, 492 citations indexed

About

Douglas A. Bergman is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Douglas A. Bergman has authored 15 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 6 papers in Infectious Diseases. Recurrent topics in Douglas A. Bergman's work include Click Chemistry and Applications (8 papers), HIV/AIDS drug development and treatment (6 papers) and Protein Structure and Dynamics (5 papers). Douglas A. Bergman is often cited by papers focused on Click Chemistry and Applications (8 papers), HIV/AIDS drug development and treatment (6 papers) and Protein Structure and Dynamics (5 papers). Douglas A. Bergman collaborates with scholars based in Australia, New Zealand and United States. Douglas A. Bergman's co-authors include David P. Fairlie, Darren R. March, Giovanni Abbenante, Donald J. Winzor, Robert C. Reid, Jennifer L. Martin, Paul F. Alewood, E. C. Foulkes, Joel D. A. Tyndall and Christina L. L. Chai and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Analytical Biochemistry.

In The Last Decade

Douglas A. Bergman

15 papers receiving 471 citations

Peers

Douglas A. Bergman
Paul S. Furth United States
Matthew Bennett United States
Timothy J. Allison United States
Kendra E. Hightower United States
Gabriela Mustata United States
Paul S. Furth United States
Douglas A. Bergman
Citations per year, relative to Douglas A. Bergman Douglas A. Bergman (= 1×) peers Paul S. Furth

Countries citing papers authored by Douglas A. Bergman

Since Specialization
Citations

This map shows the geographic impact of Douglas A. Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas A. Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas A. Bergman more than expected).

Fields of papers citing papers by Douglas A. Bergman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas A. Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas A. Bergman. The network helps show where Douglas A. Bergman may publish in the future.

Co-authorship network of co-authors of Douglas A. Bergman

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas A. Bergman. A scholar is included among the top collaborators of Douglas A. Bergman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas A. Bergman. Douglas A. Bergman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tyndall, Joel D. A., Robert C. Reid, David Tyssen, et al.. (2000). Synthesis, Stability, Antiviral Activity, and Protease-Bound Structures of Substrate-Mimicking Constrained Macrocyclic Inhibitors of HIV-1 Protease. Journal of Medicinal Chemistry. 43(19). 3495–3504. 51 indexed citations
2.
Fairlie, David P., Joel D. A. Tyndall, Robert C. Reid, et al.. (2000). Conformational Selection of Inhibitors and Substrates by Proteolytic Enzymes:  Implications for Drug Design and Polypeptide Processing. Journal of Medicinal Chemistry. 43(7). 1271–1281. 133 indexed citations
3.
Martin, Jennifer L., Jakob Begun, Aaron Schindeler, et al.. (1999). Molecular Recognition of Macrocyclic Peptidomimetic Inhibitors by HIV-1 Protease,. Biochemistry. 38(25). 7978–7988. 36 indexed citations
4.
Abell, Andrew D., et al.. (1997). Simple cis-epoxide-based inhibitors of HIV-1 protease. Bioorganic & Medicinal Chemistry Letters. 7(22). 2853–2856. 6 indexed citations
5.
Abbenante, Giovanni, Douglas A. Bergman, Darren R. March, et al.. (1996). Structure-activity relationships for macrocyclic peptidomimetic inhibitors of HIV-1 protease. Bioorganic & Medicinal Chemistry Letters. 6(21). 2531–2536. 11 indexed citations
6.
March, Darren R., Giovanni Abbenante, Douglas A. Bergman, et al.. (1996). Substrate-Based Cyclic Peptidomimetics of Phe-Ile-Val That Inhibit HIV-1 Protease Using a Novel Enzyme-Binding Mode. Journal of the American Chemical Society. 118(14). 3375–3379. 67 indexed citations
7.
Abbenante, Giovanni, et al.. (1995). Regioselective structural and functional mimicry of peptides. Design of hydrolytically-stable cyclic peptidomimetic inhibitors of HIV-1 protease.. Journal of the American Chemical Society. 117(41). 10220–10226. 47 indexed citations
8.
Bergman, Douglas A., Dianne Alewood, Paul F. Alewood, et al.. (1995). Kinetic properties of HIV-1 protease produced by total chemical synthesis with cysteine residues replaced by isosteric L-?-amino-n-butyric acid. Letters in Peptide Science. 2(2). 99–107. 11 indexed citations
9.
Bergman, Douglas A., et al.. (1995). A novel thioether linker: Chemical synthesis of a HIV-1 protease analogue by thioether ligation. Tetrahedron Letters. 36(48). 8871–8874. 41 indexed citations
10.
Foulkes, E. C. & Douglas A. Bergman. (1993). Inorganic Mercury Absorption in Mature and Immature Rat Jejunum: Transcellular and Intercellular Pathways in Vivo and in Everted Sacs. Toxicology and Applied Pharmacology. 120(1). 89–95. 33 indexed citations
11.
Bergman, Douglas A., Keith E. Shearwin, & Donald J. Winzor. (1989). Effects of thermodynamic nonideality on the kinetics of ester hydrolysis by α-chymotrypsin: A model system with preexistence of the isomerization equilibrium. Archives of Biochemistry and Biophysics. 274(1). 55–63. 14 indexed citations
12.
Bergman, Douglas A. & Donald J. Winzor. (1989). Space-filling effects of inert solutes as probes for the detection and study of substrate-mediated conformational changes by enzyme kinetics: Theoretical considerations. Journal of Theoretical Biology. 137(2). 171–189. 14 indexed citations
13.
Bergman, Douglas A. & Donald J. Winzor. (1989). Thermodynamic nonideality in enzyme catalysis. European Journal of Biochemistry. 185(1). 91–97. 12 indexed citations
14.
Bergman, Douglas A. & Donald J. Winzor. (1986). Quantitative affinity chromatography: Increased versatility of the technique for studies of ligand binding. Analytical Biochemistry. 153(2). 380–386. 14 indexed citations
15.
Bergman, Douglas A., et al.. (1980). Anomalous electrophoretic behavior of creatine kinase: A thiol-dependent isomeric system with migration subject to kinetic control. Archives of Biochemistry and Biophysics. 202(2). 558–564. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026